Emerging Technology
Over the years, Gentex has systematically transformed itself into a technology company, vertically integrated and proficient in a wide range of unique core competencies. Today, Gentex is growing its product portfolio and transforming its tech not only for automotive uses, but also entirely new markets
Wireless Power & Data Applications
Gentex is partnering with Solace to further develop, manufacture, and commercialize Solace’s unique wireless power systems within a wide variety of industries.
FEATURES/BENEFITS:
- Wireless power and data technology
- Transmit through barriers like glass, wood and concrete
- Replace wire harnesses
- Unaffected by extreme conditions; not corrosive like traditional connectors
- Streamlined design; eliminates slip rings and brushes that degrade and contribute to bulky designs
- Deliver heat to various surface - induced currents efficiently transfers energy for defrosting/demisting without direct contact
- Applications in automotive, telecommunications, aerospace & defense, smart home, industrial automation
Dynamic Surgical Task Lighting
Gentex is co-developing a smart lighting system for surgical and patient-care environments that allows medical staff to place focused illumination when and where it’s needed.
FEATURES/BENEFITS:
- Hands-free, camera-controlled smart lighting for surgery suites
- Flush-mount ceiling design
- Automatically directs light where it’s needed
- Shadow mitigation technology
- Brightness and color temperature controls
- Hands-free interface
- Paddle or monitor control
- Eliminates glare from fluids and instruments
- Clinical trials currently underway
AI Medical Imaging
Gentex is partnering with RetiSpec to commercialize technology for the early detection of Alzheimer’s disease. RetiSpec is an artificial intelligence (AI) medical imaging company developing a tool for the early detection of disease biomarkers in the eye.
The Technology
- By harnessing hyperspectral imagery, the technology allows for the rapid, simple and cost-effective identification of Alzheimer's biomarkers years before the emergence of clinical symptoms
- In preclinical and feasibility studies, the retinal imaging technology was effective in detecting small changes in biomarkers associated with elevated cerebral amyloid beta levels early in the disease process
- Test can be performed fully onsite and seamlessly integrated into clinical workflow to streamline decision making
- Offers significant potential savings to the healthcare system and increasing the efficiency of therapeutic clinical trials
eSightGo - Digital Device for Central Vision Loss
Gentex Acquisition – January 2024
FEATURES/BENEFITS:
- Mobile electronic eyewear that allows those with visual impairments to perform daily living tasks
- Improves functional vision for more than 20 different eye conditions
- High-definition camera, proprietary algorithms, and powerful processing platform relays imagery onto high-resolution screens positioned before each eye
